Skip to main content
Addgene
Open Menu

Enter a sequence to perform a BLAST-based search of Addgene plasmid sequence databases.

Information

In Category

Filter By

We narrowed to 40,419 results for: kan

Clear keywords
Showing: 941 - 960 of 40419 results

  12. pAAV-EF1a>WAChR_1m-G-Soma-E-HA-P2A-mScarlet; WPRE3-BGH polyA; KanR

    Plasmid
    #247728
    Purpose
    Constitutive bicistronic expression via P2A cleavage: {WAChR-1m}-{Kir2.1 Golgi tag}-{Kv2.1 soma tag}-{Kir2.1 ER tag}-{HA tag} + {mScarlet}
    Depositor
    Alexander Naka
    Article
    Tose et al bioRxiv 2025.09.12.675947; doi: https://
    Insert
    WAChR_1m-G-Soma-E-HA-P2A-mScarlet
    Use
    AAV
    Tags
    mScarlet
    Expression
    Mammalian
    Mutation
    S122L/F240A
    Promoter
    EF1a
    Available Since
    Dec. 19, 2025
    Availability
    Academic Institutions and Nonprofits only
    247728-plasmid-map-sequence-id-495882

    Enlarge

  13. pNQL001-WAPL-AID[71-114]-eGFP-FRT-Neo/Kan-FRT targeting construct

    Plasmid
    #175549
    Purpose
    Targeting vector to introduce an AID-eGFP cassette at the mouse WAPL locus using Neomycin/Kanamycin selection. Auxin-inducible degron system.
    Depositor
    Elzo de Wit
    Article
    Liu et al Nat Genet. 2021 Jan;53(1):100-109. doi:
    Insert
    WAPL (Wapl Mouse)
    Use
    Mouse Targeting
    Tags
    AID[71-114]-eGFP
    Expression
    Mammalian
    Mutation
    none
    Available Since
    Nov. 5, 2021
    Availability
    Academic Institutions and Nonprofits only
    175549-plasmid-map-sequence-id-345088

    Enlarge

  16. The Expanded CRISPEY Kit

    Plasmid Kit
    #1000000257
    Purpose
    Use the Expanded CRISPEY Kit for CRISPR-based gene editing of S. cerevisiae.
    Depositor
    Jeffrey Lewis
    Available Since
    May 6, 2025
    Availability
    Academic Institutions and Nonprofits only

  17. pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine (AAV8)

    Viral Prep
    #228902-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine (#228902). In addition to the viral particles, you will also receive purified pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine plasmid DNA. CAG-driven, Cre dependent expression of a peripherally restricted DREADD. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Article
    Kang et al Cell. 2024 Dec 26;187(26):7433-7449.e20.
    Promoter
    Chicken Beta Actin
    Tags
    mCitrine
    Available Since
    Oct. 8, 2025
    Availability
    Academic Institutions and Nonprofits only

  18. pAAV.GFA104.PI.eGFP.WPRE.bGH (AAV5)

    Viral Prep
    #100896-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV.GFA104.PI.eGFP.WPRE.bGH (#100896). In addition to the viral particles, you will also receive purified pAAV.GFA104.PI.eGFP.WPRE.bGH plasmid DNA. GFA104-driven eGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Philip Haydon
    Article
    Ortinski et al Nat Neurosci. 2010 May;13(5):584-91. doi
    Promoter
    GFA104 (GFAP promoter)
    Tags
    EGFP
    Available Since
    April 6, 2018
    Availability
    Academic Institutions and Nonprofits only

  19. pAAV-DIO-ATLASsnFlp (AAV8)

    Viral Prep
    #232352-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-DIO-ATLASsnFlp (#232352). In addition to the viral particles, you will also receive purified pAAV-DIO-ATLASsnFlp plasmid DNA. Syn-driven, ATLASsnFlp expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Don Arnold
    Article
    Rivera et al Nat Methods. 2025 May;22(5):1101-1111. d
    Promoter
    Syn
    Available Since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only

  20. pAAV-DIO-BACE-HA (AAV8)

    Viral Prep
    #232353-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-DIO-BACE-HA (#232353). In addition to the viral particles, you will also receive purified pAAV-DIO-BACE-HA plasmid DNA. Syn-driven, Beta-Secretase expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Don Arnold
    Article
    Rivera et al Nat Methods. 2025 May;22(5):1101-1111. d
    Promoter
    Syn
    Available Since
    Nov. 13, 2025
    Availability
    Academic Institutions and Nonprofits only
Showing: 941 - 960 of 40419 results